HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Tomislav Mihaljevic Edward R. Nowicki Eugene H. Blackstone Luigi Lagazzi James Thomas Bruce W. Lytle Delos M. Cosgrove Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Mihaljevic, T. Articles by Cosgrove, D. M. Search for Related Content PubMed Articles by Mihaljevic, T. Articles by Cosgrove, D. M. Related Collections Valve disease Related Article

J Thorac Cardiovasc Surg 2008;135:1270-1279
© 2008 The American Association for Thoracic Surgery

Surgery for Acquired Cardiovascular Disease

Survival after valve replacement for aortic stenosis: Implications for decision making

^a Department of Thoracic and Cardiovascular Surgery, Cleveland Clinic, Cleveland, Ohio
^b Department of Quantitative Health Sciences, Cleveland Clinic, Cleveland, Ohio
^c Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, Ohio

Received for publication May 2, 2007; revisions received November 29, 2007; accepted for publication December 18, 2007.

^_* Address for reprints: Tomislav Mihaljevic, MD, Department of Thoracic and Cardiovascular Surgery, Cleveland Clinic, 9500 Euclid Avenue/Desk F24, Cleveland, OH 44195. (Email: mihaljt{at}ccf.org).

Objective: Recommendations for aortic valve replacement in severe aortic stenosis are based primarily on the presence of symptoms. However, the onset of symptoms is often insidious, potentially leading to delayed intervention and suboptimal results. Identifying factors that reduce the survival of patients undergoing aortic valve replacement could lead to revised treatment guidelines and improved outcomes.

Methods: We conducted a single-center observational clinical study of 3049 patients with aortic stenosis who underwent native aortic valve replacement with a single type of bioprosthesis. The primary end point was all-cause mortality from the date of operation. Multivariable analysis of risk factors for death was performed in the multiphase hazard function domain.

Results: The presence of severe left ventricular hypertrophy at operation, which preceded symptoms in 17% of patients, was associated with decreased survival. This effect was magnified by the severity of aortic stenosis (P = .02) and use of small prostheses (P = .01). The presence of left ventricular dysfunction reduced survival (P = .0003). Although older age was a risk factor for death (P < .0001), elderly patients had survival comparable to their age, race, and sex-matched cohorts, whereas younger patients had worse than expected survival that was further diminished with insertion of a small prosthesis (P = .01).

Conclusion: To optimize survival, earlier aortic valve replacement should be considered even in asymptomatic patients before severe left ventricular hypertrophy or dysfunction develops. In younger patients, the largest possible prosthesis should be implanted to minimize residual gradient; in elderly patients, complex operations just to insert larger prostheses should be avoided.

Related Article

Discussion
J. Thorac. Cardiovasc. Surg. 2008 135: 1278-1279. [Extract] [Full Text] [PDF]

This article has been cited by other articles:

				Z. Hachicha, J. G. Dumesnil, and P. Pibarot Usefulness of the valvuloarterial impedance to predict adverse outcome in asymptomatic aortic stenosis. J. Am. Coll. Cardiol., September 8, 2009; 54(11): 1003 - 1011. [Abstract] [Full Text] [PDF]

				V. Delgado, L. F. Tops, R. J. van Bommel, F. van der Kley, N. A. Marsan, R. J. Klautz, M. I.M. Versteegh, E. R. Holman, M. J. Schalij, and J. J. Bax Strain analysis in patients with severe aortic stenosis and preserved left ventricular ejection fraction undergoing surgical valve replacement Eur. Heart J., September 2, 2009; (2009) ehp351v1. [Abstract] [Full Text] [PDF]

				P. Schoenhagen, E. M. Tuzcu, S. R. Kapadia, M. Y. Desai, and L. G. Svensson Three-dimensional imaging of the aortic valve and aortic root with computed tomography: new standards in an era of transcatheter valve repair/implantation Eur. Heart J., September 1, 2009; 30(17): 2079 - 2086. [Abstract] [Full Text] [PDF]

				E. L. Hannan, Z. Samadashvili, S. J. Lahey, C. R. Smith, A. T. Culliford, R. S.D. Higgins, J. P. Gold, and R. H. Jones Aortic Valve Replacement for Patients With Severe Aortic Stenosis: Risk Factors and Their Impact on 30-Month Mortality. Ann. Thorac. Surg., June 1, 2009; 87(6): 1741 - 1749. [Abstract] [Full Text] [PDF]

				S. H. Rahimtoola The Year in Valvular Heart Disease J. Am. Coll. Cardiol., May 19, 2009; 53(20): 1894 - 1908. [Full Text] [PDF]

				S. Leontyev, T. Walther, M. A. Borger, S. Lehmann, A. K. Funkat, A. Rastan, J. Kempfert, V. Falk, and F. W. Mohr Aortic valve replacement in octogenarians: utility of risk stratification with EuroSCORE. Ann. Thorac. Surg., May 1, 2009; 87(5): 1440 - 1445. [Abstract] [Full Text] [PDF]

				M. Thomas Trans-catheter aortic valve implantation in the United Kingdom: NICE guidance Heart, April 1, 2009; 95(8): 674 - 675. [Full Text] [PDF]

				B. R. Osswald, V. Gegouskov, D. Badowski-Zyla, U. Tochtermann, G. Thomas, S. Hagl, and E. H. Blackstone Overestimation of aortic valve replacement risk by EuroSCORE: implications for percutaneous valve replacement Eur. Heart J., January 1, 2009; 30(1): 74 - 80. [Abstract] [Full Text] [PDF]

				D. Garcia, P. G. Camici, L.-G. Durand, K. Rajappan, E. Gaillard, O. E. Rimoldi, and P. Pibarot Impairment of coronary flow reserve in aortic stenosis J Appl Physiol, January 1, 2009; 106(1): 113 - 121. [Abstract] [Full Text] [PDF]